Planet 13 Holdings (PLNH) EBIT Margin (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly EBIT Margin of 26.91% for Q1 2026, down 332.0% year-over-year from 11.6% in Q1 2025, and down 47.45% quarter-over-quarter from 18.25% in Q4 2025.
Planet 13 Holdings (PLNH) EBIT Margin (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported EBIT Margin for 6 consecutive years, with 26.91% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin fell 332.0% year-over-year to 26.91%; the TTM figure through Mar 2026 stood at 60.51% (down 2887.0% YoY), while the FY2025 annual figure was 57.35%, down 2684.0% from the prior year.
- EBIT Margin eased to 26.91% in Q1 2026 per PLNH's latest filing, from 18.25% in the prior quarter.
- Across five years, EBIT Margin topped out at 6.4% in Q2 2022 and bottomed at 177.5% in Q3 2023.
- Historically, EBIT Margin has averaged 49.1% across 5 years, with a median of 18.25% in 2025.
- Annual changes were most pronounced in 2022 — EBIT Margin surged 62424 bps — and 2025, when it sank 16691 bps.
- Planet 13 Holdings' EBIT Margin stood at 156.33% in 2022, then soared by 74 bps to 39.92% in 2023, then tumbled by 107 bps to 82.5% in 2024, then soared by 78 bps to 18.25% in 2025, then tumbled by 47 bps to 26.91% in 2026.
- Business Quant data shows PLNH's EBIT Margin at 26.91% in Q1 2026, 18.25% in Q4 2025, and 177.25% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 54.56 Mn | 38.08 Mn | 12.32 Mn | -12.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.62% |
| Mar 31, 2026 | -26.91% |
| Dec 31, 2025 | -18.25% |
| Sep 30, 2025 | -177.25% |
| Jun 30, 2025 | -25.42% |
| Mar 31, 2025 | -23.59% |
| Dec 31, 2024 | -82.50% |
| Sep 30, 2024 | -10.34% |
| Jun 30, 2024 | -11.39% |
| Mar 31, 2024 | -16.02% |
| Dec 31, 2023 | -39.92% |
| Sep 30, 2023 | -177.50% |
| Jun 30, 2023 | -13.56% |
| Mar 31, 2023 | -17.77% |
| Dec 31, 2022 | -156.33% |
| Sep 30, 2022 | -17.14% |
| Jun 30, 2022 | -6.40% |
| Mar 31, 2022 | -14.44% |
| Dec 31, 2021 | 8.32% |
| Sep 30, 2021 | -21.03% |